Advisory: Alerts on ImmunityBio's Trial Results wrongly tagged to Ibex Ltd
10/11/2022 23:04
Nov 10 (Reuters) - Alerts on ImmunityBio Inc's IBRX.O
trial results being published in monthly journal were wrongly
tagged to IT services provider Ibex Ltd IBEX.O . The alerts
were published from a press release issued by ImmunityBio, an
immunotherapy company, unrelated to Ibex.
For correctly tagged alerts, click on FWN326ATD
STORY_NUMBER: FWN32693E
STORY_DATE: 10/11/2022
STORY_TIME: 09:13:43
Recent news on IBEX
See all newsIbex Ltd reports results for the quarter ended June 30 - Earnings Summary
Ibex Q4 revenue rises 12% on growth across verticals
Ibex Ltd expected to post earnings of 85 cents a share - Earnings Preview
Brief: IBEX Limited Announces $20 Million Share Repurchase Program
Pakistan court ruling clears path for TRG founder's return, raises governance concerns (updated)